SEARCH

SEARCH BY CITATION

References

  • 1
    Martin MJ, Muotri A, Gage F et al. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 2005; 11: 228232.
  • 2
    Perez-Pena R. 3 City Institutions to Get $50 Million for Stem Cell Research. The New York Times. May 23, 2005. B: 2.
  • 3
    Schworm P. Hospital Receives $6M for Stem Cell Research. The Boston Globe. March 14, 2005. B: 2.
  • 4
    Johnson LA. Proposed Funding Could Keep NJ a Leader in Stem Cell Research. The Associated Press. January 10, 2005.
  • 5
    The Stem Cell Institute of New Jersey. New Jersey Commission on Science & Technology, 2005. Available at http://www.state.nj.us/scitech/stem_intro.html. Accessed June 7, 2005.
  • 6
    Pazniokas M. Landmark Stem Cell Financing Bill Passes. The Hartford Courant. June 1, 2005. A: 1.
  • 7
    Hwang WS, Roh SI, Lee BC et al. Patient-specific embryonic stem cells derived from human SCNT blastocysts. Science 2005; 308: 17771783.
  • 8
    National Research Council and Institute of Medicine. (U.S.) Committee for Human Embryonic Stem Cell Research. Guidelines for Human Embryonic Stem Cell Research. Washington, D.C.: National Academies Press, 2005.
  • 9
    Food and Drug Administration. Eligibility Determinations for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products. 21 CFR Parts 210, 211, 820, and 1271.
  • 10
    Friedman LM, Furberg CD, DeMets DL. Fundamentals of Clinical Trials. New York: Springer, 1998:34.
  • 11
    What Are the Phases of Clinical Trials? National Institutes of Health, May 9,2005. Available at http://www.clinicaltrials.gov/ct/info/whatis#phases. Accessed June 6, 2005.
  • 12
    King NM, Henderson GE, Churchill LR et al. Consent forms and the therapeutic misconception: the example of gene transfer research. IRB 2005; 27: 18.
  • 13
    Dodd RY. Bovine spongiform encephalopathy, variant CJD, and blood transfusion: beefer madness? Transfusion 2004; 44: 628630.
  • 14
    Klein HG. Will blood transfusion ever be safe enough? JAMA 2000; 284: 238240.
  • 15
    Dawson L, Bateman-House AS, Mueller Agnew D et al. Safety issues in cell-based intervention trials. Fertil Steril 2003; 80: 10771085.
  • 16
    Lo B, Chou V, Cedars MI et al. Informed consent in human oocyte, embryo, and embryonic stem cell research. Fertil Steril 2004; 82: 559563.
  • 17
    Magnus D, Cho MK. Issues in Oocyte Donation for Stem Cell Research. Science Express, May 19, 2005. Available at http://www.sciencemag.org/cgi/content/full/1114454/DC. Accessed June 8, 2005.
  • 18
    Health Privacy Project. Medical Privacy Stories. November 10, 2003. Available at http://www.healthprivacy.org/newsletter-url2306/newsletter-url_list.htm?section=Privacy%20Stories%20%26%20other%20HPP%20Fact%20Sheets. Accessed June 14, 2005.
  • 19
    Wolf LE, Zandecki J, Lo B. The certificate of confidentiality application: a view from the NIH Institutes. IRB 2004; 26: 1418.
  • 20
    Joffe S, Cook EF, Cleary PD et al. Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet 2001; 358: 17721777.
  • 21
    Lidz CW, Appelbaum PS. The therapeutic misconception: problems and solutions. Med Care 2002; 40(suppl):V55V63.
  • 22
    Horng S, Emanuel E, Wilfond B et al. Descriptions of benefits and risks in consent forms for phase 1 oncology trials. N Engl J Med 2002; 347: 21342140.
  • 23
    Gordon EJ, Daugherty CK. Referral and decision making among advanced cancer patients participating in phase I trials at a single institution. J Clin Ethics 2001; 12: 3138.
  • 24
    Henderson GE, Davis AM, King NM et al. Uncertain benefit: investigators' views and communications in early phase gene transfer trials. Mol Ther 2004; 10: 225231.
  • 25
    Freed CR, Greene PE, Breeze RE et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001; 344: 710719.
  • 26
    Olanow CW, Goetz CG, Kordower JH et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 2003; 54: 403414.
  • 27
    Recombinant DNA Advisory Committee. NIH Guidance on Informed Consent for Gene Transfer Research. National Institutes of Health, December 2003. Available at http://www4.od.nih.gov/oba/rac/ic/index.html. Accessed June 7, 2005.
  • 28
    National Bioethics Advisory Commission. Ethical and Policy Issues in Research Involving Human Participants. Bethesda, MD: National Bioethics Advisory Commission, 2001.
  • 29
    Berg J, Lidz CW, Appelbaum PS. Informed Consent: Legal Theory and Clinical Practice. New York: Oxford University Press, 2001.
  • 30
    Hatch Urges Senate Action on Stem Cell Bill. May 25, 2005. Available at http://hatch.senate.gov/index.cfm?FuseAction=PressReleases.Detail&PressRelease_id=1353. Accessed June 2, 2005.
  • 31
    Espo D. Poll of Republican voters shows approval of embryonic stem cell research. The Associated Press. May 10, 2005.
  • 32
    Calvan B. Calif. Ballot Measure Set to Ignite Stem Cell Research Debate; Nancy Reagan's Advocacy Could Sway Voters. The Boston Globe. June 27, 2004. A: 18.
  • 33
    Woodsong C, Karim QA. A model designed to enhance informed consent: experiences from the HIV prevention trials network. Am J Public Health 2005; 95: 412419.
  • 34
    Fitzgerald DW, Marotte C, Verdier RI et al. Comprehension during informed consent in a less-developed country. Lancet 2002; 360: 13011302.
  • 35
    Fox R, Swazey J. The Courage to Fail. Chicago: The University of Chicago Press, 1978.
  • 36
    Fox R. Experiment Perilous: Physicians and Patients Facing the Unknown. Philadelphia: University of Pennsylvania Press, 1974.
  • 37
    Lo B, Wolf LE. Ethical issues in clinical research: an issue for all internists. Am J Med 2000; 109: 8285.
  • 38
    Orkin SH, Motulsky AG. Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy. December 7, 1995. Available at http://www.nih.gov/news/panelrep.html. Accessed June 14, 2005.